Cite
MLA Citation
Xinxue Liu et al.. “Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.” Lancet, vol. 398, no. 10303, 2021, pp. 856–869. http://access.bl.uk/ark:/81055/vdc_100160125209.0x000056